Sectors
VOR
Vor Biopharma Inc.
22.88
1 x 22.98
1 x 23.11
bid
ask
-
0.49
2.10%
09:39 AM
timesize
| Ytd | 74.92% | |
| 1y | -42.51% |
22.80
day range
23.09
6.50
52 week range
50.20
| Open | 23.09 | Prev Close | 23.37 | Low | 22.80 | High | 23.09 | Mkt Cap | 1.24B |
| Vol | 24.11K | Avg Vol | 1.18M | EPS | -3.16 | P/E | -7.24 | Forward P/E | -6.33 |
| Beta | 1.73 | Short Ratio | 3.86 | Inst. Own | 83.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 17.69 | 200-d Avg | 15.32 | 1yr Est | 37.88 |
| Income Statement | |||
| Operating Expenses | 35.16M | ||
| Research and Development Expense | 17.60M | ||
| Selling, General and Administrative Expense | 17.57M | ||
| Operating Income | -35.16M | ||
| Net Income | -219.58M | ||
| Net Income Common Stock | -219.58M | ||
| Net Income Common Stock (USD) | -219.58M | ||
| Consolidated Income | -219.58M | ||
| Earnings per Basic Share | -5.11 | ||
| Earnings per Basic Share (USD) | -5.11 | ||
| Earnings per Diluted Share | -5.11 | ||
| Earning Before Interest & Taxes (EBIT) | -219.58M | ||
| Earning Before Interest & Taxes (USD) | -219.58M | ||
| Weighted Average Shares | 43.01M | ||
| Weighted Average Shares Diluted | 43.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 170.04M | ||
| Cash and Equivalents (USD) | 170.04M | ||
| Investments | 321.65M | ||
| Investments Current | 321.65M | ||
| Current Assets | 500.78M | ||
| Property, Plant & Equipment Net | 3.39M | ||
| Total Assets | 506.75M | ||
| Debt Current | 307.00K | ||
| Total Debt | 2.94M | ||
| Current Liabilities | 16.08M | ||
| Debt Non-Current | 2.63M | ||
| Total Liabilities | 657.17M | ||
| Accumulated Retained Earnings (Deficit) | -1.37B | ||
| Accumulated Other Comprehensive Income | -706.00K | ||
| Shareholders Equity | -150.42M | ||
| Shareholders Equity (USD) | -150.42M | ||
| Assets Non-Current | 5.97M | ||
| Total Debt (USD) | 2.94M | ||
| Liabilities Non-Current | 641.09M | ||
| Trade and Non-Trade Payables | 1.04M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 137.00K | ||
| Net Cash Flow from Financing | 74.87M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -226.61M | ||
| Capital Expenditure | -48.00K | ||
| Issuance (Purchase) of Equity Shares | 75.00M | ||
| Net Cash Flow from Investing | -263.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -263.19M | ||
| Net Cash Flow from Operations | -38.25M | ||
| Share Based Compensation | 8.87M | ||